{"id":"https://openalex.org/W4310125558","doi":"https://doi.org/10.1182/blood-2022-168947","title":"Downregulation of CD16 Surface Expression on NK Cells Is a Favorable Prognostic Factor in Acute Myeloid Leukemia","display_name":"Downregulation of CD16 Surface Expression on NK Cells Is a Favorable Prognostic Factor in Acute Myeloid Leukemia","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310125558","doi":"https://doi.org/10.1182/blood-2022-168947"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-168947","doi":"https://doi.org/10.1182/blood-2022-168947","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2022-168947","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1182/blood-2022-168947","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100706686","display_name":"Huaiyu Wang","orcid":"https://orcid.org/0000-0002-6428-081X","observed_orcids":["https://orcid.org/0000-0002-6428-081X"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huaiyu Wang","raw_affiliation_strings":["1The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100457270","display_name":"Xiaojuan Zhang","orcid":"https://orcid.org/0009-0005-1579-6851","observed_orcids":["https://orcid.org/0009-0005-1579-6851"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaojuan Zhang","raw_affiliation_strings":["2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005791561","display_name":"David N. Wald","orcid":"https://orcid.org/0000-0002-8695-1178","observed_orcids":["https://orcid.org/0000-0002-8695-1178"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Wald","raw_affiliation_strings":["3Case Western Reserve University, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Case Western Reserve University, Cleveland, OH","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101470197","display_name":"Sha Gong","orcid":"https://orcid.org/0000-0001-7044-4668","observed_orcids":["https://orcid.org/0000-0001-7044-4668"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Sha Gong","raw_affiliation_strings":["2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111433001","display_name":"Wenjuan Wang","orcid":"https://orcid.org/0000-0001-9180-2823","observed_orcids":["https://orcid.org/0000-0001-9180-2823","https://orcid.org/0009-0007-9600-9956","https://orcid.org/0009-0005-0651-6758","https://orcid.org/0000-0001-5097-7854"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenjuan Wang","raw_affiliation_strings":["2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100769830","display_name":"Jincheng Wang","orcid":"https://orcid.org/0000-0001-9345-2388","observed_orcids":["https://orcid.org/0000-0001-9345-2388"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jincheng Wang","raw_affiliation_strings":["2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China","institution_ids":["https://openalex.org/I4210121771"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":{"value":2500,"currency":"USD","value_usd":2500},"fwci":0.2872,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.46738858,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"11834","last_page":"11835"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.016699999570846558,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8190000057220459},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9340000152587891},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8769999742507935},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.4350000023841858},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.5609999895095825},{"id":"https://openalex.org/keywords/nk-cell-degranulation","display_name":"NK cell degranulation","score":0.6520000100135803},{"id":"https://openalex.org/keywords/nk-cell-exhaustion","display_name":"NK cell exhaustion","score":0.5379999876022339},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.4449999928474426}],"concepts":[{"id":"https://openalex.org/C2781462264","wikidata":"https://www.wikidata.org/wiki/Q78482053","display_name":"CD16","level":5,"score":0.8468754887580872},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.7284343242645264},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.585301399230957},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5148150324821472},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5073639750480652},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5040125250816345},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4972741901874542},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.43374043703079224},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.43168503046035767},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3144075274467468},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.28732508420944214},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26242756843566895},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.25831303000450134},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.23028457164764404},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.12227180600166321},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.0705963671207428},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-168947","doi":"https://doi.org/10.1182/blood-2022-168947","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2022-168947","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1182/blood-2022-168947","doi":"https://doi.org/10.1182/blood-2022-168947","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2022-168947","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4366283485","https://openalex.org/W2805914489","https://openalex.org/W3164904236","https://openalex.org/W4406253025","https://openalex.org/W3025363666","https://openalex.org/W4210850604","https://openalex.org/W3049701975","https://openalex.org/W3217473765","https://openalex.org/W4310103558","https://openalex.org/W2011977826"],"abstract_inverted_index":{"Introduction":[0],"Acute":[1],"myeloid":[2],"leukemia":[3],"(AML)":[4],"is":[5,67,143,430],"a":[6,111,122,248,284,426,449],"malignant":[7,57],"hematological":[8],"disease":[9],"characterized":[10],"by":[11,64,211],"poor":[12],"patient":[13],"outcomes":[14],"and":[15,104,154,193,203,207,229,266,305,358,392,421,467],"limited":[16,105],"chemotherapy":[17],"options.":[18],"The":[19,313,366,401],"rapid":[20],"advancement":[21],"of":[22,51,134,136,174,199,251,272,316,368,383,436,464,474],"immunotherapy":[23],"has":[24],"pushed":[25],"natural":[26],"killer":[27],"(NK)":[28],"cells":[29,34,38,66,142,202,274,318,374,415],"into":[30],"the":[31,60,131,159,216,219,269,276,301,309,322,326,376,396,433,462,472],"spotlight.":[32],"NK":[33,65,79,141,200,273,317,373,414],"can":[35],"eliminate":[36],"tumor":[37],"through":[39],"CD16-mediated":[40],"antibody-dependent":[41],"cellular":[42],"cytotoxicity":[43],"(ADCC).":[44],"Previous":[45],"studies":[46,71,459],"have":[47,72,93],"found":[48],"that":[49,74,95,443],"downregulation":[50,135],"CD16":[52,76,97,137,320,369,410,444],"occurs":[53],"after":[54,196],"coculture":[55],"with":[56,148,167,247],"targets,":[58],"but":[59,288],"effects":[61],"on":[62,140,215,372,413,471],"ADCC":[63,103],"less":[68],"clear.":[69],"Several":[70],"shown":[73],"blocking":[75,96],"cleavage":[77,98],"increases":[78],"cell":[80],"attachment":[81],"to":[82,108,223,406,425,432,452],"antibody-coated":[83],"target":[84],"cells,":[85],"degranulation":[86],"(Romee":[87],"et":[88,115,438],"al.,":[89,116],"2013),":[90],"whereas":[91],"others,":[92],"reported":[94],"either":[99],"did":[100],"not":[101,291],"affect":[102],"their":[106,204],"ability":[107],"kill":[109],"in":[110,127,158,165,172,254,275,300,308,321,375,395,418],"sequential":[112],"manner":[113],"(Srpan":[114],"2018).":[117],"This":[118],"uncertainty":[119],"stems":[120],"from":[121],"disparity":[123],"between":[124,152,325],"experimental":[125],"methods":[126],"vitro.":[128],"Therefore,":[129],"understanding":[130],"clinical":[132],"significance":[133],"surface":[138,370,411],"expression":[139,371,412],"crucial.":[144],"Methods":[145],"Patients":[146],"diagnosed":[147],"de":[149],"novo":[150],"AML":[151,175,241,419,456],"2020":[153],"2022":[155],"were":[156,163,182,209,221,279,297,329],"enrolled":[157],"study.":[160,256],"All":[161],"patients":[162,220,242,299,307],"treated":[164],"accordance":[166],"NCCN":[168],"Clinical":[169],"Practice":[170],"Guidelines":[171],"Oncology":[173],"(Version":[176],"3,":[177],"2020).":[178],"Bone":[179],"marrow":[180,278,324],"samples":[181],"collected":[183],"at":[184,333,340,347,354,362,389],"month":[185,187,258,260,334,341],"0,":[186,259],"1,":[188,261],"months":[189,191,194,262,264,267,348,355,363,390,393],"1-3,":[190,263],"3-6":[192,265,356],"6-12":[195,364,394],"therapy.":[197],"Number":[198],"(CD3-CD56+)":[201],"subsets":[205],"(CD16+":[206],"CD16-)":[208],"analyzed":[210],"flow":[212],"cytometry.":[213],"Based":[214],"12-month":[217],"prognosis,":[218],"assigned":[222],"favorable":[224,302,377,427],"prognosis":[225,233,303,311,378,398,454],"group":[226,234,304,379,399],"(complete":[227],"response":[228],"survival)":[230],"or":[231,236],"unfavorable":[232,310,397],"(relapse":[235],"death).":[237],"Results":[238],"Totally":[239],"188":[240],"(108":[243],"males,":[244],"80":[245],"females)":[246],"mean":[249,270,314],"age":[250],"45.5\u00b117.9":[252],"years":[253],"this":[255],"At":[257],"6-12,":[268],"percentage":[271,315],"bone":[277,323],"11.95%\u00b10.63%\uff0c12.14%\u00b11.40%\uff0c13.02%\u00b11.31%,13.22%\u00b11.25,13.30%\u00b11.50%,":[280],"respectively.":[281],"There":[282,296],"was":[283,290,416,422],"trend":[285,382],"towards":[286],"increased,":[287],"it":[289,387],"statistically":[292],"significant":[293,403],"(P=0.12,":[294],"Fig.1).":[295],"122":[298],"66":[306],"group.":[312],"expressing":[319],"two":[327,402],"groups":[328],"74.44%\u00b12.26%":[330],"vs":[331,338,345,352,360],"74.70\u00b12.98%":[332],"0":[335],"(P=0.94),":[336,343],"53.70\u00b16.80%":[337],"52.77\u00b110.33%":[339],"1":[342],"50.85\u00b15.04%":[344],"71.85\u00b16.21%":[346],"1-3":[349,391],"(P<0.01),":[350],"38.78\u00b15.74%":[351],"47.05\u00b115.05%":[353],"(P=0.59),":[357],"22.94\u00b15.70%":[359],"78.28\u00b19.92%":[361],"(P<0.01).":[365,400],"level":[367],"showed":[380],"gradually":[381],"decrease":[384],"(P=0.02),":[385],"while":[386],"increased":[388],"peaks":[404],"correspond":[405],"adverse":[407],"event.":[408],"Conclusions":[409],"down-regulated":[417],"patients,":[420],"markedly":[423],"related":[424],"prognosis.":[428],"It":[429],"similar":[431],"previous":[434],"conclusion":[435],"Srpan":[437],"al.":[439],"These":[440],"results":[441],"indicate":[442],"may":[445],"be":[446],"used":[447],"as":[448],"potential":[450],"biomarker":[451],"predict":[453],"for":[455,477],"patients.":[457],"Future":[458],"will":[460],"explore":[461],"visibility":[463],"other":[465],"tumor,":[466],"shed":[468],"new":[469],"light":[470],"development":[473],"immunological":[475],"therapy":[476],"tumors.":[478],"Figure":[479],"1View":[480,483],"largeDownload":[481,484],"PPTFigure":[482],"PPT":[485],"Close":[486],"modal":[487]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-09T09:14:12.587421","created_date":"2022-11-30T00:00:00"}